4.4 Review

Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?

期刊

HELICOBACTER
卷 23, 期 1, 页码 -

出版社

WILEY
DOI: 10.1111/hel.12454

关键词

Alzheimer's disease; cognitive impairment; dementia; gastric inflammation; Helicobacter pylori; tauopathy

向作者/读者索取更多资源

BackgroundHelicobacter pylori has changed radically gastroenterologic world, offering a new concept in patients' management. Over time, more medical data gave rise to diverse distant, extragastric manifestations and interactions of the new discovered bacterium. Special interest appeared within the field of neurodegenerative diseases and particularly Alzheimer's disease, as the latter and Helicobacter pylori infection are associated with a large public health burden and Alzheimer's disease ranks as the leading cause of disability. However, the relationship between Helicobacter pylori infection and Alzheimer's disease remains uncertain. MethodsWe performed a narrative review regarding a possible connection between Helicobacter pylori and Alzheimer's disease. All accessible relevant (pre)clinical studies written in English were included. Both affected pathologies were briefly analyzed, and relevant studies are discussed, trying to focus on the possible pathogenetic role of this bacterium in Alzheimer's disease. ResultsData stemming from both epidemiologic studies and animal experiments seem to be rather encouraging, tending to confirm the hypothesis that Helicobacter pylori infection might influence the course of Alzheimer's disease pleiotropically. Possible main mechanisms may include the bacterium's access to the brain via the oral-nasal-olfactory pathway or by circulating monocytes (infected with Helicobacter pylori due to defective autophagy) through disrupted blood-brain barrier, thereby possibly triggering neurodegeneration. ConclusionsCurrent data suggest that Helicobacter pylori infection might influence the pathophysiology of Alzheimer's disease. However, further large-scale randomized controlled trials are mandatory to clarify a possible favorable effect of Helicobacter pylori eradication on Alzheimer's disease pathophysiology, before the recommendation of short-term and cost-effective therapeutic regimens against Helicobacter pylori-related Alzheimer's disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Gastroenterology & Hepatology

Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease

Jannis Kountouras, Apostolis Papaefthymiou, Stergios A. Polyzos, Christos Liatsos, Maria Tzitiridou-Chatzopoulou, Dimitrios Chatzopoulos, Elisabeth Vardaka, Dimitra Gialamprinou, Georgios Kotronis, Tharshika Thavayogarajah, Michael Doulberis

DIGESTIVE DISEASES AND SCIENCES (2023)

Editorial Material Peripheral Vascular Disease

Potential Impact of Helicobacter pylori-Related Metabolic Syndrome on Arterial Hypertension Outcomes

Jannis Kountouras, Apostolis Papaefthymiou, Stergios A. Polyzos, Foteini Kyrailidi, Michael Doulberis

AMERICAN JOURNAL OF HYPERTENSION (2023)

Letter Oncology

Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer Pathophysiology

Jannis Kountouras, Apostolis Papaefthymiou, Stergios A. A. Polyzos, Michael Doulberis

JOURNAL OF GASTROINTESTINAL CANCER (2023)

Letter Gastroenterology & Hepatology

Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities

Jannis Kountouras, Apostolis Papaefthymiou, Stergios A. Polyzos, Evangelos Kazakos, Dimitrios Tzilves, Maria Touloumtzi, Dimitrios Chatzopoulos, Maria Tzitiridou-Chatzopoulou, Christos Liatsos, Christos Zavos, John Kavaliotis, Hasan Kulaksiz, Michael Doulberis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Letter Gastroenterology & Hepatology

Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B

Jannis Kountouras, Apostolis Papaefthymiou, Stergios A. A. Polyzos, Evangelos Kazakos, Dimitrios Tzilves, Georgia Lazaraki, Christos Zavos, Elisabeth Vardaka, Stergios Arapoglou, Foteini Kyrailidi, Maria C. C. Mouratidou, Michael Doulberis

JOURNAL OF VIRAL HEPATITIS (2023)

Review Immunology

Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease

Jannis Kountouras, Evangelos Kazakos, Stergios A. Polyzos, Apostolis Papaefthymiou, Christos Zavos, Maria Tzitiridou-Chatzopoulou, Dimitrios Chatzopoulos, Elisabeth Vardaka, Anthia Gatopoulou, Foteini Kyrailidi, Maria C. Mouratidou, Michael Doulberis

Summary: This article discusses the potential impact of trained immunity on the pathophysiology of MAFLD, revealing the complex immunobiology of the disease and providing potential therapeutic strategies.

CLINICAL IMMUNOLOGY (2023)

Letter Geriatrics & Gerontology

Viewing the Current Puzzling Issue of COVID-19 Vaccination Safety in Older Adults

Jannis Kountouras, Apostolis Papaefthymiou, Christos Zavos, Dimitrios Chatzopoulos, Maria Tzitiridou-Chatzopoulou, John Kavaliotis, Dimitrios Tzilves, Georgia Lazaraki, Elisabeth Vardaka, Michael Doulberis

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2023)

Article Infectious Diseases

Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013-2022: Data from the European Registry on H. pylori Management (Hp-EuReg)

Olga. P. Nyssen, Pietro Pratesi, Miguel. A. Spinola, Laimas Jonaitis, Angeles Perez-Aisa, Dino Vaira, Ilaria Maria Saracino, Matteo Pavoni, Giulia Fiorini, Bojan Tepes, Dmitry. S. Bordin, Irina Voynovan, Angel Lanas, Samuel. J. Martinez-Dominguez, Enrique Alfaro, Luis Bujanda, Manuel Pabon-Carrasco, Luis Hernandez, Antonio Gasbarrini, Juozas Kupcinskas, Frode Lerang, Sinead. M. Smith, Oleksiy Gridnyev, Marcis Leja, Theodore Rokkas, Ricardo Marcos-Pinto, Antonio Mestrovic, Wojciech Marlicz, Vladimir Milivojevic, Halis Simsek, Lumir Kunovsky, Veronika Papp, Perminder. S. Phull, Marino Venerito, Lyudmila Boyanova, Doron Boltin, Yaron Niv, Tamara Matysiak-Budnik, Michael Doulberis, Daniela Dobru, Vincent Lamy, Lisette. G. Capelle, Emilijia Nikolovska Trpchevska, Leticia Moreira, Anna Cano-Catalia, Pablo Parra, Francis Megraud, Colm O'Morain, Guillermo. J. Ortega, Javier. P. Gisbert

Summary: The segmentation of patients into homogeneous groups can improve the effectiveness of eradication therapy. The study aims to determine the most important treatment strategies used in Europe and evaluate the effectiveness of first-line treatments based on year and country. The analysis found that the overall treatment effectiveness increased from 87% in 2013 to 93% in 2022, with the highest effectiveness achieved in 2022 using bismuth-quadruple therapy in Spain. Cluster analysis identified homogeneous treatment groups and assessed the effectiveness of different first-line treatments.

ANTIBIOTICS-BASEL (2023)

Review Biochemistry & Molecular Biology

Origin and Emergence of Microglia in the CNS-An Interesting (Hi)story of an Eccentric Cell

Iasonas Dermitzakis, Maria Eleni Manthou, Soultana Meditskou, Marie-eve Tremblay, Steven Petratos, Lida Zoupi, Marina Boziki, Evangelia Kesidou, Constantina Simeonidou, Paschalis Theotokis

Summary: Microglia are tissue-resident macrophages of the CNS and play a vital role in homeostasis and pathophysiology of the brain. Their unique characteristics and origin have been a subject of intense research. This review presents recent evidence on the birthplace of microglia and the molecular factors involved in their development. The data collected can potentially provide insights into the therapeutic potential of microglia for CNS disorders.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2023)

Article Medicine, General & Internal

Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration

Jannis Kountouras, Michael Doulberis, Apostolis Papaefthymiou, Stergios A. Polyzos, Christos Zavos, Evangelos Kazakos, Stergios Arapoglou, Foteini Kyrailidi, Maria C. Mouratidou, Marina Boziki, Elisabeth Vardaka

Summary: Helicobacter pylori infection is a global burden affecting over 50% of the world's population. It is not only associated with gastric pathologies like peptic ulcers and gastric cancer, but also implicated in the development of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and/or glaucoma by inducing brain cortical thinning.

MEDICINA-LITHUANIA (2023)

Article Medicine, General & Internal

COVID-19 mRNA Vaccine Effectiveness against Elderly Frail People

Jannis Kountouras, Maria Tzitiridou-Chatzopoulou, Apostolis Papaefthymiou, Dimitrios Chatzopoulos, Michael Doulberis

Summary: Frail, elderly individuals have poor immune response after COVID-19 mRNA vaccination, possibly due to inflame-ageing and immune-senescence mechanisms. The complex interaction between cytokines and microbiota also plays a role in this inflammatory cascade. Despite their immunological significance, this population has been rarely included in clinical trials of mRNA vaccination.

MEDICINA-LITHUANIA (2023)

Article Endocrinology & Metabolism

Nonalcoholic fatty liver disease test: an external validation cohort

Stergios A. Polyzos, Apostolis Papaefthymiou, Michael Doulberis, Jannis Kountouras

Summary: This study validates a novel non-invasive index, the NAFLD test, for the diagnosis of NAFLD and the distinction between NAFL and NASH, showing acceptable accuracy.

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2023)

Article Gastroenterology & Hepatology

Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines

Rahel Looser, Michael Doulberis, Jean-Benoit Rossel, Yannick Franc, Daniel Mueller, Luc Biedermann, Gerhard Rogler

Summary: There is conflicting data on whether co-treatment with 5-aminosalicylic acid (5-ASA) in inflammatory bowel disease patients under azathioprine (AZA) or 6-mercaptopurine (6-MP) therapy may affect 6-thioguanine nucleotide (6-TGN) concentrations and put patients at risk of side effects. This study aimed to determine 6-TGN levels in patients treated with AZA/6-MP, either alone or in combination with 5-ASA. The results showed that blood concentrations of 6-TGN and 6-methylmercaptopurine ribonucleotides (6-MMPR) did not differ between patients with and without 5-ASA co-treatment.

ANNALS OF GASTROENTEROLOGY (2023)

Review Endocrinology & Metabolism

Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease

Apostolis Papaefthymiou, Michael Doulberis, Kyriaki Karafyllidou, Eleftherios Chatzimichael, Georgia Deretzi, Aristomenis K. Exadaktylos, Fotios Sampsonas, Athanasios Gelasakis, Spyros I. Papamichos, Georgios Kotronis, Dimitra Gialamprinou, Elisabeth Vardaka, Stergios A. Polyzos, Jannis Kountouras

Summary: Nonalcoholic fatty liver disease (NAFLD) is a disease with unclear pathogenesis and increasing prevalence, for which there is currently no approved pharmacotherapy. This article focuses on the potential future pharmacological management of NAFLD through spironolactone, a cost-effective medication.

MINERVA ENDOCRINOLOGY (2023)

暂无数据